ConductScience.org, home

Paper35680595

[Comparison of the efficacy of IA and HAD induction regimens in the treatment of patients with newly diagnosed acute myeloid leukemia: a single-center study].

Zhang CX and 16 others. Zhonghua Xue Ye Xue Za Zhi, 2022. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. [Comparison of the efficacy of IA and HAD induction regimens in the treatment of patients with newly diagnosed acute myeloid leukemia: a single-center study]. Papers, record 35680595. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35680595

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
[Comparison of the efficacy of IA and HAD induction regimens in the treatment of patients with newly diagnosed acute myeloid leukemia: a single-center study].
PubMed
Journal
Zhonghua Xue Ye Xue Za Zhi
PubMed
Year
2022
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.06
iCite
Revised in PubMed
2024-08-31
PubMed

Authors17

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang CXC X
2Qiu SWS W
3Gong BFB F
4Gong XYX Y
5Li YY
6Liu YTY T
7Fang QYQ Y
8Zhang GJG J
9Liu KQK Q
10Zhou CLC L
11Wei SNS N
12Lin DD
13Liu BCB C
14Wang YY
15Mi YCY C
16Wei HH
17Wang JXJ X

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CytarabineMajor topic
Leukemia, Myeloid, AcuteMajor topic
Adolescent
Adult
Antineoplastic Combined Chemotherapy Protocols
Daunorubicin
Female
Homoharringtonine
Humans
Induction Chemotherapy
Male
Middle Aged
Nuclear Proteins
Prognosis
Remission Induction
Retrospective Studies
Young Adult

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2021YFC2500300National Key Research and Development Program of ChinaPubMed
2020-I2M-C&T-B-084CAMS Innovation Fund for Medical SciencesPubMed
21ZXGWSY00030Tianjin Municipal Science and Technology Commission GrantPubMed

Source PubMed

Download CSV of grants

References12

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132258060Cardiotoxicity of Anthracyclines.Front Cardiovasc Med2020https://conductscience.org/library/papers/32258060PubMed
223664707Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial.Lancet Oncol2013https://conductscience.org/library/papers/23664707PubMed
332029439Randomized Trial of Intermediate-dose Cytarabine in Induction and Consolidation Therapy in Adults with Acute Myeloid Leukemia.Clin Cancer Res2020https://conductscience.org/library/papers/32029439PubMed
423248249Superior long-term outcome with idarubicin compared with high-dose daunorubicin in patients with acute myeloid leukemia age 50 years and older.J Clin Oncol2013https://conductscience.org/library/papers/23248249PubMed
523398482Anthracyclines during induction therapy in acute myeloid leukaemia: a systematic review and meta-analysis.Br J Haematol2013https://conductscience.org/library/papers/23398482PubMed
614673054
Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia.
J Clin Oncol2003https://conductscience.org/library/papers/14673054PubMed
727069254The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.Blood2016https://conductscience.org/library/papers/27069254PubMed
827895058Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.Blood2017https://conductscience.org/library/papers/27895058PubMed
928632487Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in Induction Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia.J Clin Oncol2017https://conductscience.org/library/papers/28632487PubMed
1029090664Pharmacogenetics of Metabolic Genes of Anthracyclines in Acute Myeloid Leukemia.Curr Drug Metab2018https://conductscience.org/library/papers/29090664PubMed
1125458084Effectiveness of homoharringtonine (omacetaxine mepesuccinate) for treatment of acute myeloid leukemia: a meta-analysis of Chinese studies.Clin Lymphoma Myeloma Leuk2015https://conductscience.org/library/papers/25458084PubMed
122015395Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia.Blood1991https://conductscience.org/library/papers/2015395PubMed

Download CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
39765351[Clinical characteristics and treatment efficacy of newly diagnosed acute leukemia in the plateau].Zhonghua Xue Ye Xue Za Zhi2024https://conductscience.org/library/papers/39765351

Source PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CR11378PubTator's text mininghttps://conductscience.org/library/genes/1378NCBI Gene
ELN2006PubTator's text mininghttps://conductscience.org/library/genes/2006NCBI Gene
FLT32322PubTator's text mininghttps://conductscience.org/library/genes/2322NCBI Gene
NPM14869PubTator's text mininghttps://conductscience.org/library/genes/4869NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35680595

GET https://conductscience.org/api/papers/v1/35680595/authors